How is RRMS Different from PPMS and SPMS?

NewsGuard 100/100 Score

Multiple sclerosis (MS) is a neurodegenerative disorder that damages the nerves in the brain and spinal cord, leading to problems with muscle movement, balance, and vision. MS is an example of a demyelinating disease, where myelin, which is the protective coating that surrounds nerve fibers, becomes damaged.

Image Credit: Lightspring / Shutterstock.com

Multiple sclerosis follows a different course in every individual; however, there are three primary ways in which the disease can progress, depending on which form of the illness a patient has.

Relapsing-remitting MS

It is estimated that up to 80% of all individuals with MS have the relapsing-remitting form of the disease. These individuals have periods where their symptoms are mild or absent, which is otherwise referred to as remission, followed by periods of symptom relapse. Symptoms may occur suddenly and in acute bouts or exacerbations. During periods of relapse, symptoms may become worse each time.

The relapsing-remitting form of MS may eventually progress to secondary progressive MS (SPMS), during which there are few or no periods of remission. Relapsing-remitting multiple sclerosis (RRMS) can be diagnosed when two episodes of relapse are separated by more than 30 days, or there has only been one relapse that is accompanied by MRI evidence of newly scarred or damaged myelin three months later.

Understanding Multiple Sclerosis: Types of MS

Secondary-progressive MS

Patients with SPMS often experience phases of relapse followed by remission at first. However, as SPMS progresses, it may eventually lead to the progressive form of the disease, which is characterized by worsening symptoms and few or no periods of remission.

Primary-progressive MS

The least common form of multiple sclerosis is primary progressive MS (PPMS), which occurs in about 10% to 15% of all cases and usually in people over the age of 40. In this form of MS, symptoms worsen over time rather than occurring in bouts or as sudden attacks.

PPMS may be diagnosed if there have been no previous symptoms of relapse but the patient has become increasingly disabled over a period of at least one year.

References

Further Reading

Last Updated: Sep 24, 2022

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2022, September 24). How is RRMS Different from PPMS and SPMS?. News-Medical. Retrieved on April 19, 2024 from https://www.news-medical.net/health/How-is-RRMS-Different-from-PPMS-and-SPMS.aspx.

  • MLA

    Mandal, Ananya. "How is RRMS Different from PPMS and SPMS?". News-Medical. 19 April 2024. <https://www.news-medical.net/health/How-is-RRMS-Different-from-PPMS-and-SPMS.aspx>.

  • Chicago

    Mandal, Ananya. "How is RRMS Different from PPMS and SPMS?". News-Medical. https://www.news-medical.net/health/How-is-RRMS-Different-from-PPMS-and-SPMS.aspx. (accessed April 19, 2024).

  • Harvard

    Mandal, Ananya. 2022. How is RRMS Different from PPMS and SPMS?. News-Medical, viewed 19 April 2024, https://www.news-medical.net/health/How-is-RRMS-Different-from-PPMS-and-SPMS.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers identify key protein biomarkers in MS patients, paving way for personalized treatment strategies